CannabisNewsBreaks

TuesdayDec 22, 2020 3:00 pm

CannabisNewsBreaks – Why RYAH Group Inc. Is ‘One to Watch’

RYAH Group is a leading digital health care analytics and technology company with a mission to advance the world’s transition to remote-health solutions and data analytics in patient treatments. Through its IoT dose-measuring devices and AI analytics, RYAH is focused on expanding understanding of the value of devices combined with data to positively impact the future treatment of patients for various medical conditions. A recent article discussing the company reads, “Since it began developing and commercializing its smart inhaler solution in 2018, the company has evolved a complete IoT device and data analytics platform that includes multiple delivery mechanisms, designed…

Continue Reading

MondayDec 21, 2020 1:16 pm

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Corporate Updates, New Strategic Focus

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Friday provided an update on its 49%-owned joint venture, PharmHouse Inc. Per the update, on Oct. 29, 2020, PharmHouse received a court order from the Ontario Superior Court of Justice to initiate a sale and investment solicitation process ("SISP") to identify interest in, and opportunities for, a sale of, or investment in, all or part of PharmHouse's assets or business. This may include a restructuring, recapitalization, or other form of reorganization of PharmHouse's business and affairs. Phase one of the SISP concluded on Nov. 30, 2020,…

Continue Reading

MondayDec 21, 2020 12:18 pm

CannabisNewsBreaks – CannAssist International Corporation’s (CNSC) Xceptol Brand Available via Innovative Distribution Portal – RangeMe

CannAssist (OTCQB: CNSC) today announced approval of its Xceptol brand on the distribution website RangeMe. According to the update, RangeMe added Xceptol drops and capsules to the Xceptol pain cream products already available, bringing the number of Xceptol SKUs on the platform to 10. Additional SKUs will be added in the first quarter of 2021. RangeMe's broad network creates a significant new revenue source for CannAssist International. "This is exciting news for us on many fronts; a process estimated to take weeks was accomplished in a few days – a testament, I feel, to the quality of the Xceptol brand,"…

Continue Reading

ThursdayDec 17, 2020 11:30 am

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) to ‘Launch into 2021 with Various Exciting Projects’

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced an update for its first successful 100-acre pilot outdoor hemp CBD harvest. According to the update, the harvest yielded a quality much higher than the company’s expectations, and a yield of over 105,000 lbs in total biomass was prepared for sale and processing to Speakeasy Cannabis Club (CSE: EASY). "We are very proud of our team and partners at Rock Creek Farms who have been committed to the vision and dedicated to achieving success," said Pac Roots president and…

Continue Reading

WednesdayDec 16, 2020 3:16 pm

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Commences Trading on the OTCQB Venture Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced that it has commenced trading in the United States on the OTCQB Venture Market under the symbol "PACRF." The company anticipates that its new U.S. listing will provide greater liquidity and a more seamless trading experience for its U.S. shareholders and potential investors. "With the cannabis industry gaining momentum in the United States, this cross-border listing will increase our visibility and open the doors to new investors as well as enable exciting business opportunities," said Pac Roots president and…

Continue Reading

WednesdayDec 16, 2020 2:31 pm

CannabisNewsBreaks – Why CannAssist International Corporation (CNSC) Is ‘One to Watch’

CannAssist (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company.  Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol ("CBD") products under the Xceptol brand. A recent article discussing the company reads, “Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary process developed by CNSC founder Mark Palumbo. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life. This technology provides the basis for Xceptor Labs and Xceptol consumer products.” To view the full article, visit https://cnw.fm/EKrzX…

Continue Reading

WednesdayDec 16, 2020 11:40 am

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Announces Progress in Commercialization Plan with Initial Product Expected in Q1 2021

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) has contracted with a leading manufacturer to produce its first cannabinoid, cannabigerol ("CBG"); the first production run is slated for early 2021 and will result in commercial quantities of Willow’s ultra-pure CBG. The product will be manufactured in Europe. In addition, Willow announced plans to run a second 500-litre pilot this month in order to meet demand for customer samples and streamline the production process. These announcements mark significant progress for the company in its strategic commercialization plan. Based on progress so far, the company noted that it anticipates seeing revenue generated from this…

Continue Reading

TuesdayDec 15, 2020 3:58 pm

CannabisNewsBreaks – Gage Cannabis Co. on Rapid Growth Trajectory, Looks to Cultivate Additional Opportunity in Michigan

Gage Cannabis, a premium adult-use cannabis retailer, is set to capitalize on stunning growth of the Michigan industry. Ever since recreational use was legalized in 2018, Michigan has become one of the fastest-growing legal cannabis markets in the United States in terms of consumption. In fact, state authorities have recently projected recreational marijuana sales to be worth nearly $1 billion per annum in 2021 with revenues set to reach over $1.5 billion by 2023 (https://www.cnw.fm/rAUw9). An article discussing the company’s positioning amid this budding market reads, “Gage Cannabis has witnessed a rapid growth trajectory since its inception, having opened its…

Continue Reading

TuesdayDec 15, 2020 2:36 pm

CannabisNewsBreaks – Way2Grow (‘W2G’) Biopharma Company Announces Entry into Cannabis Productivity, Plans for Psychedelic Research and Development

Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately held biopharma company, today announced its entry into the productivity phase of cannabis cultivation, micropropagation and extraction. The company also announced its preparation of a Health Canada application towards psychedelic research and development for a medicinal mushroom (Psilocybe semilanceata) Dealer Licence and a Section 56 Exemption for use of psilocybin production and extraction for planned preclinical research under scientific purposes, per the Controlled Drugs and Substances Act (the “CDSA”). According to the update, W2G has secured approval for a single-story production facility designed to support tissue culture and micropropagation and to meet organic…

Continue Reading

TuesdayDec 15, 2020 10:52 am

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Notes Appreciation for Health Canada Milestone Special Access Programme

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has voiced its support and appreciation for Health Canada’s recently announced Special Access Programme (“SAP”) for psilocybin-assisted psychotherapy inclusion. The government entity recently announced its intent to revise the SAP and other related regulations to allow limited uses of psilocybin-assisted psychotherapeutic treatments. The SAP revision may open the door to new medical applications in the mental health space and support the progress of advanced research initiatives, including ongoing clinical trials evaluating psilocybin-assisted psychotherapy. The proposed SAP update may also positively…

Continue Reading